Fundacion MD Anderson Cancer Center

Madrid 28033

2 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumor, Colorectal Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Ductal Adenocarcinoma

Studies at this site

• Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors — Recruiting now
• A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors — Recruiting now